Mouth-dissolving Tablets Market
Mouth-dissolving Tablets Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Mouth-dissolving Tablets Market Size and Growth
The Mouth-dissolving Tablets market is experiencing significant growth, driven by increasing consumer demand for rapid onset of action and convenience. The global market size was valued at approximately $8 billion in 2023, with a projected CAGR of around 7% through 2030, reflecting rising adoption across pharmaceuticals and nutraceuticals sectors.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Teva
◍ Merck
◍ Mylan
◍ Pfizer
◍ Johnson and Johnson
◍ GSK
◍ Otsuka
◍ Eli Lilly and Company
◍ AstraZeneca
◍ Bristol-Myers Squibb
◍ Conquer
The Mouth-dissolving Tablets Market features major players like Teva, Merck, Mylan, Pfizer, Johnson & Johnson, GSK, Otsuka, Eli Lilly, AstraZeneca, and BristolMyers Squibb, focusing on innovative formulations. These companies' strategic R&D investments enhance product offerings, driving market growth. Sales figures include:
- Teva: $16 billion
- Pfizer: $41.9 billion
- Johnson & Johnson: $93.8 billion Request Sample Report
Market Segmentation
By Application
By Product
◍ Anti-Psychotics Drug ◍ Anti-Epileptics Drug ◍ Other ◍ CNS Diseases ◍ Gastrointestinal Diseases ◍ CVS Diseases ◍ Other
Request Sample Report
$ 33410.00 Million
Request Sample Report
